FAKTOR OPTIONSSCHEIN - IPSEN | Market Closed - BOERSE MUENCHEN 19:26:00 07/06/2024 BST | ||
| 15.84 EUR | +3.73% |
|
| Current month | +9.62% | ||
| 1 month | +40.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 15.84 | +3.73% |
| 06/06/24 | 15.27 | +7.54% |
| 05/06/24 | 14.2 | -2.47% |
| 04/06/24 | 14.56 | -1.62% |
| 03/06/24 | 14.8 | +6.25% |
Real-time BOERSE MUENCHEN
Last update June 07, 2024 at 07:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Goldman Sachs |
| WKN | GG3BNQ |
| ISIN | DE000GG3BNQ6 |
| Date issued | 01/02/2024 |
| Strike | 98.24 € |
| Maturity | Unlimited |
| Parity | 1.63 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.88 € |
|---|---|
| Lowest since issue | 6.19 € |
| Spread | 3 € |
| Spread % | 17.26% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
122.9
EUR
Average target price
126.4
EUR
Spread / Average Target
+2.85%
- Stock Market
- Certificates
- Certificat